comparemela.com

Latest Breaking News On - Cerevel therapeutics holdings - Page 8 : comparemela.com

AbbVie taps new CEO as it faces fresh competition for blockbuster drug Humira

AbbVie’s founding CEO Richard Gonzalez will step down July 1, the drugmaker said Tuesday.

Richard gonzalezRobert michaelGlenn tiltonAbbvie incCerevel therapeutics holdings incCerevel therapeutics holdingsArticle normalBiotechnology servicesHealthcare life sciencesManagement movesBoard of directorsCorporate industrial newsSenior level managementContent typesFactiva filtersC amp ampe executive news filter

Cerevel Therapeutics (NASDAQ:CERE) Sees Strong Trading Volume

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) shares saw an uptick in trading volume on Tuesday . 1,343,879 shares were traded during trading, a decline of 20% from the previous session’s volume of 1,682,243 shares.The stock last traded at $41.20 and had previously closed at $42.57. Analyst Upgrades and Downgrades A number of […]

United statesMark bodenraderPiper sandlerScott akamineJefferies financial groupAvoro capital advisorsJpmorgan chase coMorgan stanleyCerevel therapeutics company profileVanguard group incCerevel therapeutics holdings incPerceptive advisorsBain capital investorsCerevel therapeutics holdingsGet free reportCerevel therapeutics

Cerevel Therapeutics (NASDAQ:CERE) Sees Unusually-High Trading Volume

Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) saw strong trading volume on Tuesday . 1,343,879 shares were traded during trading, a decline of 20% from the previous session’s volume of 1,682,243 shares.The stock last traded at $41.20 and had previously closed at $42.57. Wall Street Analysts Forecast Growth A number of […]

United statesRamiro sanchezZurcher kantonalbank zurich cantonalbankScott akaminePiper sandlerTd asset management incCerevel therapeutics holdings incCharles schwab investment management incJefferies financial groupMirae asset global investments coMorgan stanleyJpmorgan chase coCerevel therapeutics holdingsGet free reportCerevel therapeuticsFinancial group

Cerevel Therapeutics (NASDAQ:CERE) Sees Unusually-High Trading Volume

Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) saw strong trading volume on Tuesday . 1,343,879 shares were traded during trading, a decline of 20% from the previous session’s volume of 1,682,243 shares.The stock last traded at $41.20 and had previously closed at $42.57. Wall Street Analysts Forecast Growth A number of […]

United statesPiper sandlerScott akamineZurcher kantonalbank zurich cantonalbankRamiro sanchezMorgan stanleyJpmorgan chase coTd asset management incCharles schwab investment management incCerevel therapeutics holdings incJefferies financial groupMirae asset global investments coCerevel therapeutics holdingsGet free reportCerevel therapeuticsFinancial group

AbbVie taps new CEO as it faces fresh competition for blockbuster drug Humira

AbbVie taps new CEO as it faces fresh competition for blockbuster drug Humira
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.

Glenn tiltonRichard gonzalezRobert michaelCerevel therapeutics holdings incAbbvie incCerevel therapeutics holdings

vimarsana © 2020. All Rights Reserved.